UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000029763
Receipt No. R000033810
Scientific Title Phase II study of Osimertinib Treatment on EGFR T790M Cytology Positive NSCLC Patients (DETECTIVE study)
Date of disclosure of the study information 2017/10/30
Last modified on 2019/06/03 10:33:39

No. Disposal Last modified on Item of update
1 Insert 2017/10/30 17:53:56
2 Update 2018/04/25 15:07:34 Recruitment status
3 Update 2018/04/25 16:47:21 Key exclusion criteria
Key exclusion criteria
4 Update 2018/10/30 09:40:39 Recruitment status
5 Update 2019/06/03 10:21:12 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Address
Address
Address
Address
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/06/03 10:30:43 Date of IRB
Last follow-up date
7 Update 2019/06/03 10:32:15 Recruitment status
8 Update 2019/06/03 10:33:39 Number of participants that the trial has enrolled


Contact us.